financetom
Market
financetom
/
Market
/
Top brokerage calls on RBL Bank: CLSA, Investec and more
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top brokerage calls on RBL Bank: CLSA, Investec and more
Dec 26, 2021 11:28 PM

Top brokerage calls on RBL Bank: CLSA, Investec and more

SUMMARY

Investec has placed its recommendation for RBL Bank 'under review' from 'buy' while ICICI Securities has downgraded its rating on the banking stock to 'sell'. Here are the top brokerage calls for today:

By CNBCTV18.comDec 27, 2021 8:28:28 AM IST (Published)

CLSA on RBL Bank | In a surprise move, the RBI appointed an additional director to RBL Bank's board which CLSA expects will lead to uncertainty in the near term. CLSA has maintained its 'outperform' rating on the lender's stock.

ICICI Securities on RBL Bank | This interim adverse development can drag RBL Bank's valuation to as low as 0.55 times FY23 book, ICICI Securities said. The brokerage has downgraded its rating on the banking stock to 'sell'.

Investec on RBL Bank | Investec has placed its recommendation for RBL Bank 'under review' from 'buy' and will update post Q3 earnings. The recent development is clearly a negative outcome from investor confidence perspective, the brokerage said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Wall St indexes edge lower as Middle East conflict persists
US STOCKS-Wall St indexes edge lower as Middle East conflict persists
Jun 17, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Indexes down: Dow 0.17%, S&P 500 0.33%, Nasdaq 0.36% * Solar stocks down as Senate proposes to phase out tax credits * Eli Lilly ( LLY ) to acquire Verve Therapeutics ( VERV ) for up to $1.3 bln...
This Little-Known Buy Now, Pay Later Stock Is Up 9,998%: Analysts Think It Still Has Room To Run
This Little-Known Buy Now, Pay Later Stock Is Up 9,998%: Analysts Think It Still Has Room To Run
Jun 17, 2025
Buy Now, Pay Later company, Sezzle Inc. ( SEZL ) is hardly on Wall Street’s radar despite posting an impressive 9,998% rally since its public listing just two years ago. What Happened: On Monday, the Schwab Network’s senior market correspondent, George Tsilis, discussed the overlooked fintech company, highlighting the key reasons for its remarkable 991% gains over the past year,...
Solar stocks plunge on Senate proposal to phase out tax credits by 2028
Solar stocks plunge on Senate proposal to phase out tax credits by 2028
Jun 17, 2025
(Reuters) -U.S. solar stocks tumbled on Tuesday after a Senate panel proposed phasing out solar and wind tax credits by 2028, as part of changes to President Donald Trump's sweeping tax-and-spending bill. Solar inverter maker Enphase Energy and solar panel manufacturer First Solar slid 27.2% and 19.3%, respectively, among the biggest decliners on the benchmark S&P 500. Other solar panel...
Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May
Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May
Jun 17, 2025
11:50 AM EDT, 06/17/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday it has agreed to acquire Verve Therapeutics ( VERV ) for up to $1.3 billion in an effort to advance its gene-editing therapies for cardiovascular disease. Lilly will pay $10.50 per share in cash, with the potential for additional payments based on clinical milestones, the companies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved